CARBOXYLIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT

Details for Australian Patent Application No. 2002309047 (hide)

Owner ONO PHARMACEUTICAL CO., LTD.

Inventors SEKO, Takuya; TERAKADO, Masahiko; KOHNO, Hiroshi; TAKAHASHI, Shinya

Pub. Number AU-A-2002309047

PCT Number PCT/JP02/04520

PCT Pub. Number WO2002/092068

Priority 2001-140458 10.05.01 JP

Filing date 9 May 2002

Wipo publication date 25 November 2002

International Classifications

A61K 031/166 - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

C07C 311/17 Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61P 001/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 001/04 Drugs for disorders of the alimentary tract or the digestive system

A61P 001/16 Drugs for disorders of the alimentary tract or the digestive system

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 009/14 Drugs for disorders of the cardiovascular system

A61P 011/00 Drugs for disorders of the respiratory system

A61P 013/12 Drugs for disorders of the urinary system

A61P 017/00 Drugs for dermatological disorders

A61P 017/02 Drugs for dermatological disorders

A61P 019/10 Drugs for skeletal disorders

A61P 027/02 Drugs for disorders of the senses

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 031/04 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 043/00 Drugs for specific purposes, not provided for in groups

C07D 213/30 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/40 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/79 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/81 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/82 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 235/12 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 265/30 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 295/14 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/89 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/16 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 031/167 - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 031/192

A61K 031/194

A61K 031/196

A61K 031/216

A61K 031/343 - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 031/381 - having five-membered rings

A61K 031/402 - 1-aryl-substituted, e.g. piretanide

A61K 031/4184

A61K 031/44 - Non-condensed pyridines

A61K 031/4402 - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 031/4409 - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 031/5375 - 1,4-Oxazines, e.g. morpholine

C07C 235/38 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 2001-140458 10.05.01 JP

1 May 2003 Application Open to Public Inspection

  Published as AU-A-2002309047

26 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002309048-INFORMATION DELIVERY SYSTEM USING CELLULAR TERMINAL

2002309046-SHOE INSOLE